Headlines about Intuitive Surgical (NASDAQ:ISRG) have trended somewhat positive on Thursday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intuitive Surgical earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 46.0981205795013 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news headlines that may have effected Accern Sentiment’s analysis:
- Is Intuitive Surgical, Inc. a Buy? (fool.com)
- Seesawing Stocks: Activision Blizzard, Inc., (NASDAQ: ATVI), Intuitive Surgical, Inc., (NASDAQ: ISRG), Grupo … – Stocks In The News (press release) (tradingnewsnow.com)
- Intuitive Surgical (ISRG) a Strong Buy on Top-End Sales Growth – Investorplace.com (investorplace.com)
- Intuitive Surgical, Inc. (ISRG) Director Sells $224,320.80 in Stock (americanbankingnews.com)
Intuitive Surgical (NASDAQ ISRG) traded down $1.28 during midday trading on Thursday, hitting $389.69. The stock had a trading volume of 579,200 shares, compared to its average volume of 970,296. Intuitive Surgical has a 12 month low of $203.57 and a 12 month high of $393.51. The firm has a market capitalization of $43,970.00, a PE ratio of 51.74, a price-to-earnings-growth ratio of 5.43 and a beta of 0.46.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. During the same period in the previous year, the firm posted $2.06 earnings per share. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. research analysts forecast that Intuitive Surgical will post 7.85 earnings per share for the current fiscal year.
A number of research analysts recently issued reports on ISRG shares. BidaskClub downgraded Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Citigroup Inc. reiterated a “buy” rating and issued a $119.78 target price (up from $101.89) on shares of Intuitive Surgical in a research note on Monday, July 24th. Stifel Nicolaus reiterated a “buy” rating and issued a $122.22 target price (up from $94.44) on shares of Intuitive Surgical in a research note on Saturday, July 22nd. Vetr upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.37 target price on the stock in a research note on Thursday, August 17th. Finally, Wedbush reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Intuitive Surgical has an average rating of “Buy” and an average price target of $155.78.
In other news, Director Lonnie M. Smith sold 580 shares of Intuitive Surgical stock in a transaction on Friday, November 10th. The stock was sold at an average price of $386.76, for a total value of $224,320.80. Following the completion of the sale, the director now owns 559,410 shares of the company’s stock, valued at $216,357,411.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Craig H. Barratt sold 15,000 shares of Intuitive Surgical stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $371.18, for a total value of $5,567,700.00. Following the completion of the sale, the insider now directly owns 7,500 shares of the company’s stock, valued at approximately $2,783,850. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,656 shares of company stock valued at $15,432,702. Insiders own 2.20% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.